Efficacy and Safety of Chidamide Combined With BEAM Pretreatment Regimen in Autologous Transplantation for T-cell Lymphoma

NCT05367856 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

23

Enrollment

OTHER

Sponsor class

Conditions

T Cell Lymphoma

Interventions

DRUG: Chidamide combined with BEAM

Sponsor

Ruijin Hospital